
CROMA Pharma, GmbH, and Bausch + Lomb (B + L) have announced the approval bromfenac sodium sesquihydrate (Yellox) by the European commission. This news follows the positive opinion issued in March by the Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency (EMA).
